Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AstaTech Biopharmaceuticals, commonly referred to as AstaTech, is a China-based pharmaceutical services company focused on small-molecule APIs, intermediates, custom synthesis, and CDMO/CMO/CRO services for global pharmaceutical and biotechnology customers. The company appears to operate primarily as a chemistry and manufacturing partner rather than as a therapeutic product developer with a disclosed clinical pipeline. Its capabilities span research, process development, analytical testing, process safety evaluation, pilot scale-up, and commercial manufacturing. Public company materials also describe activities in advanced intermediates, fine chemicals, agrochemical intermediates, and new materials. The business emphasizes green chemistry and has built multiple technical platforms including fixed-bed catalysis, synthetic biology, and continuous-flow chemistry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AstaTech Biopharmaceuticals.